We are live on ! Find out more
Point72 Asset Management

Point72 Asset Management Portfolio holdings

AUM $78.1B
1-Year Est. Return 55.25%
This Fund
S&P 500
This Quarter Est. Return
+14.81%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+1,105.06%
AUM
$41.4B
AUM Growth
+$7.08B
Cap. Flow
+$2.12B
Cap. Flow %
5.12%
Top 10 Hldgs %
16.85%
Holding
3,029
New
618
Increased
652
Reduced
507
Closed
946

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$559M
2
NVDA icon
NVIDIA
NVDA
+$505M
3
BA icon
Boeing
BA
+$218M
4
INTC icon
Intel
INTC
+$208M
5
PXD
Pioneer Natural Resource Co.
PXD
+$185M

Sector Composition

Rank Sector Weight
1 Healthcare 14.93%
2 Technology 13.49%
3 Consumer Discretionary 10.94%
4 Industrials 10.68%
5 Energy 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EW icon
1576
PUT
Edwards Lifesciences
EW
$51.7B
$427K ﹤0.01%
5,600
CSX icon
1577
PUT
CSX Corp
CSX
$93.1B
$426K ﹤0.01%
12,300
PERI icon
1578
Perion Network
PERI
$386M
$426K ﹤0.01%
+13,800
New +$392K
PVH icon
1579
PUT
PVH
PVH
$4.04B
$415K ﹤0.01%
3,400
BKE icon
1580
CALL
Buckle
BKE
$2.37B
$413K ﹤0.01%
+8,700
New +$329K
VCTR icon
1581
Victory Capital Holdings
VCTR
$6.66B
$413K ﹤0.01%
12,000
+8,200
+216% +$262K
STEM icon
1582
Stem
STEM
$52.7M
$411K ﹤0.01%
5,296
-107,740
-95% -$7.43M
RIG icon
1583
CALL
Transocean
RIG
$5.82B
$410K ﹤0.01%
64,500
VINC
1584
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$407K ﹤0.01%
17,241
QS icon
1585
QuantumScape Corp
QS
$3.74B
$402K ﹤0.01%
+57,835
New +$364K
GSHD icon
1586
Goosehead Insurance
GSHD
$2.32B
$402K ﹤0.01%
5,300
-48,242
-90% -$3.49M
TEVA icon
1587
CALL
Teva Pharmaceuticals
TEVA
$41.2B
$401K ﹤0.01%
38,400
ZS icon
1588
PUT
Zscaler
ZS
$27.3B
$399K ﹤0.01%
+1,800
New +$333K
ETRN
1589
PUT
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$397K ﹤0.01%
+39,000
New +$367K
KT icon
1590
KT
KT
$8.81B
$396K ﹤0.01%
29,500
+27,780
+1,615% +$356K
VET icon
1591
Vermilion Energy
VET
$1.66B
$396K ﹤0.01%
32,872
-354,518
-92% -$4.69M
TARS icon
1592
Tarsus Pharmaceuticals
TARS
$2.84B
$396K ﹤0.01%
19,575
-79,725
-80% -$1.33M
MUFG icon
1593
Mitsubishi UFJ Financial
MUFG
$254B
$393K ﹤0.01%
+45,600
New +$385K
COCO icon
1594
Vita Coco
COCO
$3.6B
$390K ﹤0.01%
+15,200
New +$413K
OMGA
1595
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$389K ﹤0.01%
129,389
DUK icon
1596
CALL
Duke Energy
DUK
$97.3B
$388K ﹤0.01%
4,000
STEM icon
1597
PUT
Stem
STEM
$52.7M
$388K ﹤0.01%
5,000
SSL icon
1598
Sasol
SSL
$7.1B
$386K ﹤0.01%
+38,800
New +$456K
VEEV icon
1599
CALL
Veeva Systems
VEEV
$37.4B
$385K ﹤0.01%
2,000
DOCS icon
1600
CALL
Doximity
DOCS
$5B
$381K ﹤0.01%
13,600
+200
+1% +$4.72K

Similar funds

Point72 Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Point72 Asset Management held 3,029 positions worth $41.4B, up 21% from $34.3B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Point72 Asset Management deployed $2.12B of net new capital in Q4 2023, opening 618 new positions and adding to 652 existing holdings. Its largest new stake was Oracle: 2,178,533 shares worth $230M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Microsoft, an estimated $559M trimmed.

  • Point72 Asset Management's largest Q4 2023 buy was Oracle: 2,178,533 shares worth $230M.
  • Point72 Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $247M increase.
  • Point72 Asset Management's biggest Q4 2023 reduction was Microsoft, cutting an estimated $559M.
  • Point72 Asset Management fully exited Intel in Q4 2023, selling an estimated $208M.
  • Point72 Asset Management's ten largest holdings make up 17% of its $41.4B portfolio in Q4 2023.
  • Point72 Asset Management opened 618 new positions and closed 946 in Q4 2023.
  • Point72 Asset Management's portfolio value rose 21% quarter-over-quarter to $41.4B.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.